Our work is entirely funded by private donations – we receive no money from government. Your money will help us continue funding research into vitiligo and supporting people affected by the condition.
Melanotan II with light therapy for vitiligo
Official title: A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study of Melanotan II (Synthetic Cyclic Melanocortin Receptor Agonist) as an Adjunct to Narrowband UV-B Phototherapy in Adults With Stable Nonsegmental Vitiligo
Status: Recruiting now
Description:
Hudson Biotech plans to enroll about 60 participants. Melanotan II is an unapproved synthetic hormone-like compound that stimulates melanin production. Combined with UVB light, it may increase skin pigmentation. Possible effects include nausea, flushing, appetite changes, darkening of skin or moles, and other risks that are not fully known. People ages 18 to 65 may qualify. The study is recruiting at one listed site in China.
Start date: February 02, 2026
Completion date: February 17, 2028
Organizer: Hudson Biotech
Contact: Seni S Lu, Phd
Tel.: +86 13076790030
Email: Seni-Lu@beijing-biotech.com
Clinical Trial Alerts
Sign up and be the first to know about updates on this trial.
FAQOther Questions
- Safety of clinical trials. Can my child leave it for any reason?
Pediatric vitiligo trials · Safety and choice Who watches your child, what may need to pause and what happens if your family changes its mind. Two studies discussed here are eva...
- Diabetes and Vitiligo: Is There a Connection?
Yes, there appears to be a real connection between vitiligo and diabetes, especially type 1 diabetes. A recent study using UK Biobank data also found an association with type 2 ...
- How can I explain vitiligo to my children?
Vitiligo can be confusing for children because it doesn’t resemble an "illness" in the typical sense. Choosing the right way to explain it depends on your child’s age and maturi...
Though it is not always easy to treat vitiligo, there is much to be gained by clearly understanding the diagnosis, the future implications, treatment options and their outcomes.
Many people deal with vitiligo while remaining in the public eye, maintaining a positive outlook, and having a successful career.
Copyright (C) Bodolóczki JúliaBy taking a little time to fill in the anonymous questionnaire, you can help researchers better understand and fight vitiligo.